PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
April 23, 2026Internal Medicine0 citationsOpen Access

A Case of Acute Myeloid Leukemia with MOZ::TIF2 Fusion Gene Resulting from a Novel Breakpoint

TSToma SuzukiMOMasahiro OnozawaMKMinoru Kanaya

Key Points

  • To describe a rare case of acute myeloid leukemia with a novel MOZ::TIF2 fusion gene and its diagnostic implications.
  • Performed reverse transcriptase-polymerase chain reaction (RT-PCR) to detect fusion genes
  • Conducted sequencing to identify the specific breakpoint
  • Documented clinical outcomes and challenges in diagnosis
  • Identified a previously unreported MOZ::TIF2 fusion gene with a novel breakpoint
  • Patient exhibited aggressive clinical behavior associated with this fusion
  • Previous literature reveals poor outcomes for MOZ::TIF2-positive acute myeloid leukemia cases

Abstract

We report a rare case of acute myeloid leukemia (AML) harboring an MOZ::TIF2 fusion gene with a previously unreported breakpoint. A 36-year-old man was diagnosed with AML involving inv(8)(p11.2q13). Reverse transcriptase-polymerase chain reaction (RT-PCR) initially failed to detect the conventional MOZ exon16::TIF2 exon14 fusion associated with inv(8)(p11.2q13); however, further sequencing identified a novel breakpoint of MOZ exon14::TIF2 exon12, with an additional shorter transcript lacking TIF2 exon13. MOZ::TIF2-positive AML is extremely rare, with only eight cases previously reported, and adult cases appear to have particularly poor outcomes. Our case highlights the diagnostic challenges and aggressive clinical behavior associated with MOZ::TIF2-rearranged AML.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Suzuki et al. (2026) studied this question.

synapsesocial.com/papers/69e9b71b85696592c86eb17dhttps://doi.org/10.2169/internalmedicine.7193-26
Ask AI
Helpful
Bookmark
Share
View Full Paper